oncology medicine targeted therapy egfr inhibitor

💊 Geftinat 250 mg Tablet | Gefitinib | Lung Cancer Treatment | Export Supplier Geftinat 250 mg Tablet contains Gefitinib, a targeted anticancer medicine used in the treatment of non-small cell lung cancer (NSCLC). It works by inhibiting the EGFR pathway, helping to slow down cancer cell growth and progression, especially in patients with EGFR mutations. 🔹 Product Category Oncology Medicine (Targeted Therapy / EGFR Inhibitor) 🔹 Composition Gefitinib 250 mg 🔹 Indications ✔ Non-Small Cell Lung Cancer (NSCLC) ✔ EGFR Mutation-Positive Cases 🔹 Key Benefits ✔ Targeted therapy (EGFR inhibitor) ✔ Effective in mutation-specific patients ✔ Oral treatment (patient-friendly) ✔ Widely used in oncology protocols 🔹 Dosage & Administration ✔ Oral tablet as prescribed ✔ Can be taken with or without food ✔ Dosage based on patient condition ✔ Under strict medical supervision 🔹 Packaging ✔ Blister / Bottle Packaging ✔ Bulk Export Available ✔ Private Labeling Supported 🔹 Certifications ✔ WHO-GMP Certified ✔ COA & COPP Available 🌍 Target Export Markets & Cities 🇺🇸 USA: New York, Los Angeles, Houston 🇬🇧 UK: London, Manchester 🇦🇪 UAE: Dubai, Abu Dhabi 🇸🇬 Singapore: Singapore 🇮🇳 India: Mumbai, Delhi, Bangalore 🇵🇭 Philippines: Manila 🇻🇳 Vietnam: Ho Chi Minh City, Hanoi 🇿🇦 South Africa: Johannesburg, Cape Town 🇳🇬 Nigeria: Lagos, Abuja 🇰🇪 Kenya: Nairobi 🇧🇷 Brazil: São Paulo 🇲🇽 Mexico: Mexico City 🇵🇪 Peru: Lima 📍 Location: Nagpur, Maharashtra, India 📦 Product Catalogue Available ✔ Oncology Medicines ✔ HIV & Antiviral Medicines ✔ Specialty Pharmaceutical Products 📞 Instant Support – Call / WhatsApp Now 📲 +91 8007161282 📲 +91 9970011496 💬 Quick replies for urgent orders & inquiries! 🌐 Visit Our Official Websites 🔹 www.pacificmedicines.com 🔹 www.indocares.com 🔹 www.indiamedexport.com 📧 Business Enquiries & Bulk Orders ✉️ sales@pacificmedicines.com

💊 Erlonat 150 mg Capsule | Erlotinib | Lung & Pancreatic Cancer Treatment | Export Supplier Erlonat 150 mg Capsule contains Erlotinib, a targeted anticancer medicine used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the EGFR pathway, helping to slow cancer cell growth and progression. 🔹 Product Category Oncology Medicine (Targeted Therapy / EGFR Inhibitor) 🔹 Composition Erlotinib 150 mg 🔹 Indications ✔ Non-Small Cell Lung Cancer (NSCLC) ✔ Pancreatic Cancer 🔹 Key Benefits ✔ Targeted therapy (EGFR inhibitor) ✔ Effective in mutation-specific cases ✔ Oral capsule (patient-friendly) ✔ Widely used in oncology protocols 🔹 Dosage & Administration ✔ Oral capsule as prescribed ✔ Usually taken on an empty stomach ✔ Dosage based on patient condition ✔ Under strict medical supervision 🔹 Packaging ✔ Blister / Bottle Packaging ✔ Bulk Export Available ✔ Private Labeling Supported 🔹 Certifications ✔ WHO-GMP Certified ✔ COA & COPP Available 🌍 Target Export Markets & Cities 🇺🇸 USA: New York, Los Angeles, Houston 🇬🇧 UK: London, Manchester 🇦🇪 UAE: Dubai, Abu Dhabi 🇸🇬 Singapore: Singapore 🇮🇳 India: Mumbai, Delhi, Bangalore 🇵🇭 Philippines: Manila 🇻🇳 Vietnam: Ho Chi Minh City, Hanoi 🇿🇦 South Africa: Johannesburg, Cape Town 🇳🇬 Nigeria: Lagos, Abuja 🇰🇪 Kenya: Nairobi 🇧🇷 Brazil: São Paulo 🇲🇽 Mexico: Mexico City 🇵🇪 Peru: Lima 📍 Location: Nagpur, Maharashtra, India 📦 Product Catalogue Available ✔ Oncology Medicines ✔ HIV & Antiviral Medicines ✔ Specialty Pharmaceutical Products 📞 Instant Support – Call / WhatsApp Now 📲 +91 8007161282 📲 +91 9970011496 💬 Quick replies for urgent orders & inquiries! 🌐 Visit Our Official Websites 🔹 www.pacificmedicines.com 🔹 www.indocares.com 🔹 www.indiamedexport.com 📧 Business Enquiries & Bulk Orders ✉️ sales@pacificmedicines.com

💊 Erlonat 100 mg Tablet | Erlotinib | Lung & Pancreatic Cancer Treatment | Export Supplier Erlonat 100 mg Tablet contains Erlotinib, a targeted anticancer medicine used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the EGFR pathway, helping to slow down cancer cell growth and progression. 🔹 Product Category Oncology Medicine (Targeted Therapy / EGFR Inhibitor) 🔹 Composition Erlotinib 100 mg 🔹 Indications ✔ Non-Small Cell Lung Cancer (NSCLC) ✔ Pancreatic Cancer 🔹 Key Benefits ✔ Targeted therapy (EGFR inhibitor) ✔ Effective in specific genetic mutations ✔ Oral administration (patient-friendly) ✔ Widely used in oncology protocols 🔹 Dosage & Administration ✔ Oral tablet as prescribed ✔ Usually taken on an empty stomach ✔ Dosage based on patient condition ✔ Under strict medical supervision 🔹 Packaging ✔ Blister / Bottle Packaging ✔ Bulk Export Available ✔ Private Labeling Supported 🔹 Certifications ✔ WHO-GMP Certified ✔ COA & COPP Available 🌍 Target Export Markets & Cities 🇺🇸 USA: New York, Los Angeles, Houston 🇬🇧 UK: London, Manchester 🇦🇪 UAE: Dubai, Abu Dhabi 🇸🇬 Singapore: Singapore 🇮🇳 India: Mumbai, Delhi, Bangalore 🇵🇭 Philippines: Manila 🇻🇳 Vietnam: Ho Chi Minh City, Hanoi 🇿🇦 South Africa: Johannesburg, Cape Town 🇳🇬 Nigeria: Lagos, Abuja 🇰🇪 Kenya: Nairobi 🇧🇷 Brazil: São Paulo 🇲🇽 Mexico: Mexico City 🇵🇪 Peru: Lima 📍 Location: Nagpur, Maharashtra, India 📦 Product Catalogue Available ✔ Oncology Medicines ✔ HIV & Antiviral Medicines ✔ Specialty Pharmaceutical Products 📞 Instant Support – Call / WhatsApp Now 📲 +91 8007161282 📲 +91 9970011496 💬 Quick replies for urgent orders & inquiries! 🌐 Visit Our Official Websites 🔹 www.pacificmedicines.com 🔹 www.indocares.com 🔹 www.indiamedexport.com 📧 Business Enquiries & Bulk Orders ✉️ sales@pacificmedicines.com